Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy slide image

Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy

Highly experienced and diverse Corporate Officers 1 Not exhaustive Colin Bond Chief Financial Officer Richard Saynor Chief Executive Officer Ingrid Sollerer Group General Counsel Tripti Jha Chief People Officer Pierre Bourdage Chief Commercial Officer Claire D'Abreu-Hayling Chief Scientific Officer Glenn Gerecke Chief Manufacturing and Supply Officer Rebecca Guntern President Europe Alcon Bristol Myers Squibb evotec GSK Keren Haruvi President North America MSD Note: The third-party trademarks above are property of their respective owners; 1. Proposed Corporate Officers of Sandoz Group AG. 6 Management Presentation Francisco Ballester President International NOVARTIS Phion sanofi teva VIFOR PHARMA SANDOZ
View entire presentation